Emory Training Program in Translational Research to End the HIV Epidemic
Project Number5T32AI157855-04
Former Number1T32AI157855-01
Contact PI/Project LeaderKELLEY, COLLEEN F Other PIs
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Project Abstract
In this application entitled `Emory Training Program in Translational Research to End the HIV Epidemic',
we propose a new T32 training program focused on translational HIV science located at the epicenter of the
US HIV epidemic in the Southern US at Emory University in Atlanta, GA. Our training program will provide 2
years of support to 5 post-doctoral fellows and a summer internship opportunity for 2 pre-doctoral under-
represented minority (URM) students to conduct cutting-edge HIV research through hands-on experience and
formal didactics and also educate trainees on the broader context of HIV research across the translational
continuum. Our training program will be fully integrated with and capitalize on the significant HIV research
portfolio of the Emory Center for AIDS Research (CFAR) and span the spectrum of ongoing HIV research
activities in 3 major areas of focus: 1. Laboratory-based basic science, vaccine, and cure research, 2.
Patient-centered clinical research, and 3. Public health and implementation science. Our training
program will encompass research activities in each of the NIH HIV/AIDS research priorities to reduce the
incidence of HIV, develop next generation HIV therapeutics, conduct research towards an HIV cure, and
address HIV associated co-morbidities, co-infections and complications; but, more importantly, our program
will also expose trainees to cross-cutting areas of HIV research and team science to accelerate the translation
of discovery into improved health outcomes. We have assembled a team of 35 diverse and experienced
mentors across the 3 HIV research focus areas and designed didactic opportunities for our mentees to
complement their research projects and expand their understanding of bench to bedside to community
translation of HIV research innovation. In addition, the geographic position of our training program located in
and surrounded by 4 of the counties named as focus areas for the Department of Health and Human Services
Ending the HIV Epidemic (EHE) initiative further demonstrates the urgency to develop and support the next
generation of HIV investigators specifically at our institution. Given the gravity of the HIV epidemic in the South
and globally and the new DHHS initiative that proposes to end the US HIV epidemic in the next 10 years,
fostering the next generation of translational HIV scientists across the HIV research continuum is of utmost
importance. Post-doctoral trainees will emerge from our T32 program ready for scientific independence and
with a deep understanding of how their research fits into the multidirectional and multidisciplinary framework of
HIV research with the long-term goal of ending the HIV epidemic.
Public Health Relevance Statement
Project Narrative
Given the gravity of the HIV epidemic in the South and globally and the new DHHS initiative that
proposes to end the US HIV epidemic in the next 10 years, fostering the next generation of
translational HIV scientists across the HIV research continuum is of utmost importance. To
accomplish this, we propose a new HIV T32 training program for post-doctoral fellows at Emory
University. Post-doctoral trainees will emerge from our T32 program ready for scientific
independence and with a deep understanding of how their research fits into the multidirectional
and multidisciplinary framework of HIV research with the long-term goal of ending the HIV
epidemic.
NIH Spending Category
No NIH Spending Category available.
Project Terms
EpidemicHIVTraining ProgramsTranslational Research
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
25-August-2021
Project End Date
31-July-2026
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$504,152
Direct Costs
$502,906
Indirect Costs
$35,712
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$504,152
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5T32AI157855-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32AI157855-04
Patents
No Patents information available for 5T32AI157855-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32AI157855-04
Clinical Studies
No Clinical Studies information available for 5T32AI157855-04
News and More
Related News Releases
No news release information available for 5T32AI157855-04
History
No Historical information available for 5T32AI157855-04
Similar Projects
No Similar Projects information available for 5T32AI157855-04